Hussein Sweiti
Vice President, Oncology Clinical R&D Pfizer
Seminars
Tuesday 13th October 2026
Setting the Scene for Novel Combination Partner Approaches for Vedotin-Based ADCs Including PADCEV – VIRTUAL PRESENTATION
2:00 pm
- Laying out the transformative clinical performance of Padcev-Keyruda combination including event free survival in MIBC
- Addressing the need and opportunity for novel combinations partners to enhance Padcev clinical impact
- Breaking down emerging Padcev combinations in bladder cancer and lung cancer
